» Articles » PMID: 20538274

Short-term Safety and Efficacy of the Trans-oral Endoscopic Restrictive Implant System for the Treatment of Obesity

Overview
Date 2010 Jun 12
PMID 20538274
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Medical treatment of obesity often fails, and surgical treatment, although successful, is aggressive.

Objective: To evaluate the short-term safety and efficacy of an endoscopic restrictive implant procedure in the treatment of obesity.

Design: Prospective, observational study.

Setting: Tertiary-care referral hospital in The Netherlands.

Patients: This study involved 13 patients with body mass indexes of between 40 and 50 kg/m(2) or between 35 and 40 kg/m(2) with obesity-related comorbidities.

Intervention: A new transoral endoscopic restrictive implant procedure in the treatment of obesity.

Main Outcome Measurements: Safety of the procedure, percentage of excess weight loss, change in body mass index.

Results: In 1 patient, the procedure was abandoned after a gastric perforation related to stapler malfunctioning. In 2 patients, pneumoperitoneum was detected. This was desufflated with a percutaneous hollow needle in one patient and treated conservatively in the other. After these complications, technical adjustments were made in the procedure, and no subsequent procedural complications were seen. At 3 months postprocedure, patients obtained a median excess weight loss of 28%. Median body mass index decreased from 42.1 to 37.9 kg/m(2).

Limitations: Small number of patients.

Conclusion: Preliminary results of this transoral endoscopic restrictive implant system for the treatment of obesity showed successful placement in 12 of 13 patients. Procedural complications occurred in 3 patients. Weight loss was comparable to that of laparoscopic gastric band placement. Further long-term studies are under way.

Citing Articles

Efficacy and Mechanisms of Gastric Volume-Restriction Bariatric Devices.

Wang Y, Kassab G Front Physiol. 2021; 12:761481.

PMID: 34777019 PMC: 8585502. DOI: 10.3389/fphys.2021.761481.


The Role of Minimally Invasive and Endoscopic Technologies in Morbid Obesity Treatment: Review and Critical Appraisal of the Current Clinical Practice.

Carrano F, Peev M, Saunders J, Melis M, Tognoni V, Lorenzo N Obes Surg. 2019; 30(2):736-752.

PMID: 31802407 DOI: 10.1007/s11695-019-04302-8.


Development of Bariatric and Metabolic Endoscopy.

Li S, Wang Y, Zhang S Chin Med J (Engl). 2017; 131(1):88-94.

PMID: 29271386 PMC: 5754964. DOI: 10.4103/0366-6999.221283.


Upper Gastrointestinal Function in Morbidly Obese Adolescents Before and 6 Months After Gastric Banding.

Singendonk M, Kritas S, Omari T, Feinle-Bisset C, Page A, Frisby C Obes Surg. 2017; 28(5):1277-1288.

PMID: 29103072 DOI: 10.1007/s11695-017-3000-3.


Endoscopic Bariatric and Metabolic Therapies: Surgical Analogues and Mechanisms of Action.

Jirapinyo P, Thompson C Clin Gastroenterol Hepatol. 2016; 15(5):619-630.

PMID: 27989851 PMC: 5444453. DOI: 10.1016/j.cgh.2016.10.021.